Lyka Labs Limited has provided an update on its ongoing amalgamation process with Lyka Exports Limited, revealing a slight delay in the proceedings. The National Company Law Tribunal (NCLT), Ahmedabad Bench, has requested additional information from the Income Tax Department before moving forward with the case.

NCLT Directs Income Tax Department to Submit Report

According to the latest intimation from Lyka Labs, the NCLT has directed the Income Tax Department to submit its report within seven days regarding the joint petition filed by both Lyka Labs and Lyka Exports. This development comes after the NCLT had previously reserved the matter for formal pronouncement, indicating 'no objection' in due course.

Timeline of Events

• 8th August: Lyka Labs informed stakeholders that the joint petition for the Scheme of Amalgamation was reserved by the NCLT for formal pronouncement.
• 17th September: The NCLT directed the Income Tax Department to submit its report within seven days.
• 18th September: Lyka Labs issued an intimation to the stock exchanges regarding the NCLT's latest directive.
• 9th October: The case is scheduled for further consideration by the NCLT.

Implications for Shareholders

While the request for an Income Tax Department report introduces a short delay in the amalgamation process, it appears to be a standard procedural step. Shareholders and investors of both Lyka Labs and Lyka Exports should note that this development is part of the due diligence process typically associated with corporate amalgamations.

Company's Transparency

Lyka Labs has maintained transparency throughout the amalgamation process, promptly informing the stock exchanges and shareholders about the developments. The company has made the information available on its website ( www.lykalabs.com ) for easy access by stakeholders.

Looking Ahead

The market will be closely watching the outcome of the NCLT's consideration on October 9. This date could potentially bring more clarity on the progress of the amalgamation scheme between Lyka Labs and Lyka Exports.

Investors and interested parties are advised to keep an eye on further announcements from the company as the amalgamation process moves forward.

Lyka Labs Limited (BSE: 500259, NSE: LYKALABS) has announced a significant development in its proposed merger with Lyka Exports Limited. The National Company Law Tribunal (NCLT) Ahmedabad Bench has reserved its order for formal pronouncement on the merger, indicating 'no objection' to the scheme of amalgamation.

Key Highlights

• The NCLT hearing took place on August 7, 2025
• Lyka Labs Limited is the transferee company, while Lyka Exports Limited is the transferor company
• The NCLT has reserved its order, stating 'no objection' to the merger scheme
• Formal pronouncement of the order is pending

Merger Details

The proposed merger between Lyka Labs Limited and Lyka Exports Limited has reached a crucial stage. The Joint Petition filed by both companies was heard by the NCLT Ahmedabad Bench, which has jurisdiction over both the transferor and transferee companies.

NCLT's Stance

During the hearing on August 7, 2025, the NCLT reserved its order for formal pronouncement. Importantly, the tribunal has indicated 'no objection' to the scheme of amalgamation, suggesting a positive outlook for the merger's approval.

Company's Response

Kunal Gandhi, Managing Director & CEO of Lyka Labs Limited, stated in a regulatory filing, "The company will separately make necessary disclosure once the NCLT order is formally pronounced." This approach underscores the company's commitment to transparency and compliance with regulatory requirements.

Market Impact

While the final order is yet to be formally pronounced, the NCLT's 'no objection' stance is likely to be viewed positively by investors and stakeholders. The merger, if approved, could potentially lead to synergies and enhanced operational efficiencies for the combined entity.

Next Steps

Investors and market participants will be keenly awaiting the formal pronouncement of the NCLT order. Lyka Labs has assured that it will make the necessary disclosures once the order is officially pronounced.

The company has made this information available on its website ( www.lykalabs.com ) and has duly informed the stock exchanges as part of its regulatory obligations under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

As the merger process progresses, stakeholders will be watching closely for further developments and the potential impact on Lyka Labs' future operations and market position.